DE SB331 | 2023-2024 | 152nd General Assembly
Status
Spectrum: Slight Partisan Bill (Democrat 4-2)
Status: Engrossed on June 20 2024 - 50% progression
Action: 2024-06-26 - Reported Out of Committee (Health & Human Development) in House with 12 On Its Merits
Text: Latest bill text (Draft #1) [HTML]
Status: Engrossed on June 20 2024 - 50% progression
Action: 2024-06-26 - Reported Out of Committee (Health & Human Development) in House with 12 On Its Merits
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act revises ยงยง 4732 and 4733 of the Uniform Controlled Substances Act, Subchapter III, Chapter 47, Title 16 of the Delaware Code, pertaining to the regulation of the manufacture, distribution and dispensing of controlled substances. The revisions provide that out-of-state practitioners who wish to prescribe controlled substances in Delaware pursuant to a practice privilege, interstate compact license, telehealth registration, or military registration, must obtain a Delaware controlled substance registration. This Act will ensure that these out-of-state practitioners are subject to Delaware regulation with respect to prescribing controlled substances to Delaware patients.
Title
An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.
Sponsors
Sen. Nicole Poore [D] | Rep. Debra Heffernan [D] | Sen. Brian Pettyjohn [R] | Rep. Kerri Harris [D] |
Rep. Jeff Hilovsky [R] | Rep. Edward Osienski [D] |
Roll Calls
2024-06-20 - Senate - Senate Third Reading (Y: 18 N: 0 NV: 0 Abs: 3) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-06-26 | Reported Out of Committee (Health & Human Development) in House with 12 On Its Merits | |
2024-06-25 | Assigned to Health & Human Development Committee in House | |
2024-06-20 | Passed By Senate. Votes: 18 YES 3 ABSENT | |
2024-06-18 | Reported Out of Committee (Health & Social Services) in Senate with 1 Favorable, 5 On Its Merits | |
2024-06-13 | Introduced and Assigned to Health & Social Services Committee in Senate |